Trials / Conditions / Non-hematologic Malignancy
Non-hematologic Malignancy
5 registered clinical trials studyying Non-hematologic Malignancy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant NCT05968170 | Neena Kapoor, M.D. | N/A |
| Unknown | Metabolic and Immunological Phenotyping in Patients With Cancer NCT04285242 | CCTU- Cancer Theme | — |
| Completed | Open-label Study of Surufatinib in Japanese Patients NCT05077384 | Hutchmed | Phase 1 / Phase 2 |
| Completed | Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records NCT03625557 | Guardant Health, Inc. | — |
| Completed | A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclit NCT02412722 | Millennium Pharmaceuticals, Inc. | Phase 1 |